Prevention of Edema After Coronary Artery Bypass Graft by Customized Pressure-guided Elastic Bandages

NCT06603961 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2026-02-09

No results posted yet for this study

Summary

The study aimed to assess the efficacy of customized pressure-guided elastic bandages (CPG-EB) in preventing postoperative edema and complications in Coronary Artery Bypass Graft (CABG) patients. While compression therapy, like compressive stockings, has benefits in preventing edema, concerns about affordability persist. CPG-EB provides optimal sub-bandage pressure, proven effective in venous leg ulcers. Implementing CPG-EB post-CABG could enhance venous blood flow, reducing complications and improving outcomes. Patients were divided into two groups: one with CPG-EB and the other standard post-CABG care. Data collected at 1, 2, and 6 weeks post-surgery assessed swelling and wound complications. Comparative analysis used standardized criteria.

Conditions

  • Limb Edema
  • Surgical Site Infections
  • Leg Swelling
  • Compression Bandages
  • Coronary Artery Bypass Graft
  • CABG
  • Saphenectomy
  • Saphenous Vein
  • Delayed Wound Healing
  • Post Operative Complications
  • Post Operative Surgical Site Infection

Interventions

DEVICE

CPG-EB group

Customized-pressure guided elastic bandage group

Sponsors & Collaborators

  • Siriraj Hospital

    lead OTHER

Principal Investigators

  • Prompak Nitayavardhana, MD · Siriraj Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-19
Primary Completion
2026-03-31
Completion
2026-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06603961 on ClinicalTrials.gov